Pulsed Field Ablation Challenges Conventional Devices in AF

In the ADVENT trial, pulsed field ablation, a new technology for terminating drug-refractory paroxysmal AF, was noninferior to conventional thermal ablation but had potential advantages.

Related Keywords

Gentofte , Hovedstaden , Denmark , New York , United States , Boston , Massachusetts , Copenhagen , Køavn , Viveky Reddy , Biosense Webster , Arrhythmia Services , Gentofte University Hospital , European Society Of Cardiology , Medtronic , Boston Scientific , Cardiac Arrhythmia Services , Mount Sinai Hospital , European Society , New England Journal , Presented August , Atrial Fibrillation , F Atrial Fibrillation , Tablation , Catheter Ablation , Arrhythmia , Veins , Esophagus , Oesophageal , Nerves , Refractory , Stroke , Erebrovascular Accident , Va Cerebrovascular Accident , Cryoablation , Europe , European , Healthcare And Medical Technology , Ealth And Medical Tech , Ealth And Med Tech , Ealth And Medical Technology ,